Platelet function predicts myocardial damage in patients with acute myocardial infarction

Circulation

Volumn 110, Issue 11, 2004, Pages 1392-1397

  Frossard, Martin ^a   Fuchs, Ingrid ^a   Leitner, Judith M ^a   Hsieh, Kety ^b   Vlcek, Marianne ^a   Losert, Heidrun ^a   Domanovits, Hans ^a   Schreiber, Wolfgang ^a   Laggner, Anton N ^a   Jilma, Bernd ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical University Vienna ^*

Author keywords

Collagen; Creatine kinase; Myocardial infarction; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; CREATINE KINASE MB; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EMERGENCY WARD; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; THORAX PAIN; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; AGED; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ASPIRIN; CARDIOVASCULAR AGENTS; COLLAGEN; COMORBIDITY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; PEPTIDES; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TICLOPIDINE; TYROSINE; VON WILLEBRAND FACTOR;

EID: 4544304784     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000141575.92958.9C     Document Type: Article

References (34)

1. Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation. 1999;100:614-620.
2. Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation. 1995;92:1693-1696.
3. Ott I, Neumann FJ, Gawaz M, et al. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 1996;94:1239-1246.
4. Sarma J, Laan CA, Alam S, et al. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation. 2002;105:2166-2171.
5. Yusuf S, Mehta SR, Zhao F, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003;107:966-972.
6. Boersma E, Akkerhuis KM, Theroux P, et al. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999;100:2045-2048.
7. Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation. 2001;104:2767-2771.
8. Turitto VT, Weiss HJ, Zimmerman TS, et al. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood. 1985;65:823-831.
9. Hantgan RR, Hindriks G, Taylor RG, et al. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood. 1990;76:345-353.
10. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255-265.
11. Goto S, Sakai H, Goto M, et al. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation. 1999;99:608-613.
12. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351-355.
13. Thompson SG, Kienast J, Pyke SD, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635-641.
14. Derhaschnig U, Laggner AN, Roggla M, et al. Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. Clin Chem. 2002;48:1924-1930.
15. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106:1893-1900.
16. Ryan TJ, Antman EM, Brooks, NH et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016-1030.
17. Alpert JS, Thygesen K, Antman, E et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959-969.
18. Reiter RA, Mayr F, Blazicek H, et al. Desmopressin and platelets antagonize the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood. 2003;102:4594-4599.
19. Favaloro EI. Clinical application of the PFA-100. Curr Opin Hematol. 2002;9:407-415.
20. Harrison P. Progress in the assessment of platelet function. Br J Haematol. 2000;111:733-744.
21. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med. 2001;138:152-163.
22. Ziegler S, Maca T, Alt E, et al. Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients. Platelets. 2002;13:493-497.
23. Homoncik M, Jilma B, Hergovich N, et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost. 2000;83:316-321.
24. Jilma-Stohlawetz P, Hergovich N, Homoncik M, et al. Impaired platelet function among platelet donors. Thromb Haemost. 2001;86:880-886.
25. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595-1604.
26. Tamura A, Watanabe T, Nasu M. Association between neutrophil counts on admission and left ventricular function in patients successfully treated with primary coronary angioplasty for first anterior wall acute myocardial infarction. Am J Cardiol. 2001;88:678-680.
27. Barron HV, Cannon CP, Murphy SA, et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000;102:2329-2334.
28. Homoncik M, Blann AD, Hollenstein U, et al. Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100. Br J Haematol. 2000;111:1250-1252.
29. Margulis T, David M, Maor N, et al. The von Willebrand factor in myocardial infarction and unstable angina: a kinetic study. Thromb Haemost. 1986;55:366-368.
30. Rentrop KP. Thrombi in acute coronary syndromes: revisited and revised. Circulation, 2000;101:1619-1626.
31. Derhaschnig U, Pachinger C, Jilma B. Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial. Am Heart J. 2004;147:E17.
32. Machin SJ, Clarke C, Ikemura O, et al. A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiC of activity and platelet adhesion in human volunteers. J Thromb Haemost. 2003;1(suppl 1):OC328.
33. Madan M, Berkowitz SD, Christie DJ, et al. Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. Am Heart J. 2002;144:151-158.
34. Lincoff AM. Targeting the use of platelet IIb/IlIa inhibitors: treatment of acute myocardial infarction. Rev Cardiovasc Med. 2002;3(suppl 1):S13-S19.